Interleukin‐13: prospects for new treatments
- 15 December 2009
- journal article
- review article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 40 (1) , 42-49
Abstract
Summary: IL‐13 is a T‐helper type 2 cytokine. Animal models have implicated IL‐13 as a critical cytokine in the development of asthma and chronic obstructive pulmonary disease (COPD). In vitro IL‐13 exerts important effects on both structural and inflammatory cells within the airway and has the capacity to drive the clinical features of airways disease. In asthma, this view is strongly supported by associations with IL‐13 genetic polymorphisms and increased mRNA and protein expression in blood, sputum and bronchial submucosa. In particular, IL‐13 up‐regulation is associated with severe disease. Current evidence in COPD is conflicting, with some reports supporting and others refuting a role for IL‐13. Early clinical trials of anti‐IL‐13 therapies in asthma have shown promise, and the results of further efficacy studies are eagerly awaited. Cite this as: C. E. Brightling, S. Saha and F. Hollins, Clinical & Experimental Allergy, 2010 (40) 42–49.Keywords
This publication has 90 references indexed in Scilit:
- IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitisBMC Pulmonary Medicine, 2009
- Persistent activation of an innate immune response translates respiratory viral infection into chronic lung diseaseNature Medicine, 2008
- Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 SystemCell, 2008
- Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort studyRespiratory Research, 2007
- Asthma Control during the Year after Bronchial ThermoplastyNew England Journal of Medicine, 2007
- Mast cell migration to Th2 stimulated airway smooth muscle from asthmaticsThorax, 2006
- Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary diseaseClinical and Experimental Immunology, 2006
- Decreased expression of interleukin 13 in human lung emphysemaThorax, 2004
- STAT-1 is activated by IL-4 and IL-13 in multiple cell typesMolecular Immunology, 2004
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993